Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F98M1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,772
Award facts
- Contract value 100% obligated
- $14,771.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14.8K to Amerisourcebergen Drug Corp for the supply of RINVOQ ER 15 mg tablets (30-count units) on February 2, 2026, with an ultimate completion date of February 3, 2026. This is a firm fixed-price, non-set-aside competitive award, with performance based in Conshohocken, Pennsylvania. The delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), is a major pharmaceutical distributor serving as a critical federal medical procurement vendor. The company maintains an extensive portfolio of delivery orders with DLA covering diverse therapeutic domains including specialty medications, brand-name and generic drugs, vaccines, and medical devices. Cencora, Inc. also holds a separate, longer-term IDC with DLA Troop Support Medical valued at up to $999.9 million through December 31, 2031, further establishing the company's significant role in supporting military and federal healthcare supply chains.
Quick answers
Who was awarded contract SPE2DR26F98M1?
SPE2DR26F98M1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 2, 2026.
How much is contract SPE2DR26F98M1 worth?
The government has obligated $14,772 on SPE2DR26F98M1.
Is contract SPE2DR26F98M1 an order under another contract?
Yes. SPE2DR26F98M1 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F98M1 competed?
The extent of competition for SPE2DR26F98M1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award